Company Biolidics Limited

Equities

8YY

SGXE89830751

Advanced Medical Equipment & Technology

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sales per Business

Sales per region

Annual profits - Rate of surprise

Sector Other Advanced Medical Equipment & Technology

Delayed Singapore S.E. Other stock markets 04:27:11 2024-04-17 am EDT			5-day change	1st Jan Change
0.012 ^SGD	0.00%		0.00%	-14.29%

Apr. 12	Biolidics Limited Announces the Redesignation of Zhu Hua from Non-Executive Non-Independent Director to Executive Director	CI
Apr. 12	Singapore Shares Fall at Market Close; Biolidics Up 9%	MT

Biolidics Limited is a Singapore-based precision medicine medical technology company. The Company's principal activities are technology development, technology transfer, marketing, selling and distribution of biomedical technology, life and medicine science related products and services; provision of laboratory services; and investment holding. It has three segments: cancer diagnostics, infectious diseases and laboratory services. Cancer diagnostics segment develops and commercializes the ClearCell FX1 System, a fully automated CE-IVD medical device, which separate and enrich cancer cells from blood, allows users of the system to perform liquid biopsies. Infectious diseases segment develops, markets and/or distributes certified test kits with various diagnostic partners. Laboratory services segment offers a range of tests. The laboratory has a regulatory approval from Singaporeâs Ministry of Health for molecular microbiology testing and PCR testing services for COVID-19 in Singapore.

SGD in Million	2022	Weight	2023	Weight	Delta
Laboratory Services 78.9 %	2	77.8 %	1	78.9 %	-46.46%
Cancer 21.1 %	0	8.4 %	0	21.1 %	+33.65%

SGD in Million	2022	Weight	2023	Weight	Delta
Singapore 78.7 %	2	87.1 %	1	78.7 %	-52.28%
Thailand 6.8 %	-	-	0	6.8 %	-
Japan 5.0 %	0	1.3 %	0	5.0 %	+106.25%
Malaysia 4.9 %	-	-	0	4.9 %	-
Hong Kong 2.9 %	0	3.1 %	0	2.9 %	-51.28%
United States 1.1 %	-	-	0	1.1 %	-
Europe 0.5 %	0	0.8 %	0	0.5 %	-65.00%
Philippines 0.2 %	0	0.6 %	0	0.2 %	-85.71%

Managers	Title	Age	Since
Tang Yih Song CEO	Chief Executive Officer	59	21-08-31
Hafiza Alwi Nor SEC	Corporate Secretary	-	-
Yeung Sau Siu AUD	Comptroller/Controller/Auditor	50	22-05-31

Members of the board	Title	Age	Since
Tang Yih Song CEO	Chief Executive Officer	59	21-08-31
Li-Ling Ch'ng BRD	Director/Board Member	53	23-03-30
Yoke Pheng Liew BRD	Director/Board Member	68	Nov. 26
Ian David Brown BRD	Director/Board Member	-	21-06-13
Hua Zhu BRD	Director/Board Member	47	Nov. 30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	744,758,836	402,564,406 ( 54.05 %)	0	54.05 %

Biolidics Ltd.

Novelty BizCentre 18 Howard Road

369585, Singapore

http://www.biolidics.com

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
BIOLIDICS LIMITED	-14.29%	6.55M
THERMO FISHER SCIENTIFIC	+3.10%	212B
DANAHER CORPORATION	+3.48%	178B
INTUITIVE SURGICAL, INC.	+10.91%	134B
BOSTON SCIENTIFIC CORPORATION	+17.56%	100B
SIEMENS HEALTHINEERS AG	-0.99%	62.45B
EDWARDS LIFESCIENCES CORPORATION	+14.41%	54.2B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-6.21%	44.74B
AGILENT TECHNOLOGIES, INC.	-3.22%	40.09B
GE HEALTHCARE TECHNOLOGIES INC.	+10.18%	39.19B

Other Advanced Medical Equipment & Technology